Daniel Files, MD
Pulmonary Disease · Winston Salem, NCNPI 1376690248
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,270 of the $4,311 with a category attached, or 99.0%. Global Blood Therapeutics, Inc. accounts for 99.0% of it on its own, with 3 other manufacturers making up the rest. 2022 is the largest year on record at $4,283, more than ten times the $15 reported in 2020.
Across 4 payments — averaging $1077.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Global Blood Therapeutics, Inc.$4K
- AbbVie$15
- GSK$14
- Hikma Pharmaceuticals USA$13
Across 4 payments — averaging $16,164 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Omeros Corporation$62K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Genentech, Inc.$1K
What the payments were for
- Consulting fees$4,27099%
- Food & beverage$411%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Global Blood Therapeutics, Inc. | 1 | $4,270 |
| AbbVie | 1 | $15 |
| GSK | 1 | $14 |
| Hikma Pharmaceuticals USA | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OXBRYTA$4,270
How this compares
$4,311 in reported general payments places this provider in the 65th percentile of 393 pulmonary disease providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Winston Salem
- Eugene BleeckerWinston Salem$357K
- Jill OharWinston Salem$226K
- Stephen PetersWinston Salem$59K
- Jessica FieldWinston Salem$55K
- Wendy MooreWinston Salem$48K
- Christina BellingerWinston Salem$32K
- Kapilkumar PatelWinston Salem$21K
- Chad MarionWinston Salem$17K
- Andrew NamenWinston Salem$16K
- Victor OrtegaWinston Salem$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.